Global Biologics Outsourcing Market Growth Prospects, Future Industry Landscape 2032 | AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Lonza Group Ag, Catalent Inc., Sartorius Stedim Biotech S.A

The Biologics Outsourcing Global Market Report 2023, provides comprehensive information on the biologics outsourcing market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Biologics Outsourcing Market’s Growth:

As per The Business Research Company’s Biologics Outsourcing Global Market Report 2023, the global biologics outsourcing market is expected to grow from $15.44 billion in 2022 to $17.74 billion in 2023 at a compound annual growth rate (CAGR) of 14.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The biologics outsourcing market is expected to reach $29.39 billion in 2027, at a CAGR of 13.4%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

Developments in biologics are a key trend gaining popularity in the biologics outsourcing market. Major companies operating in the biologics outsourcing market are adopting new technologies to sustain their position in the market. For instance, in February 2022, Abzena, a US-based contract development and manufacturing organization (CDMO), Alira Health, a US-based healthcare firm, and Oncodesign, a France-based biopharmaceutical company, launched DRIVE-Biologics, a consortium designed for biologic drug discovery and development programs. This provides integrated solutions with specialist services, from biological discovery to clinical and commercial manufacturing. This partnership, which combines industry leadership in fields such as design and developability, proof of concept in preclinical pharmacology and pharmaco-imaging, toxicology, and clinical design through commercial manufacturing, would streamline information sharing and program deliverables to help de-risk biologics development. Additionally, partners would have access to expertise at all drug discovery and development stages, including design, preclinical, clinical, and CMC (chemistry, manufacturing, and control).

The biologics outsourcing market is segmented:

1) By Product Type: Antibodies, Recombinant, Vaccines, Protein, Other Products

2) By Source: Human, Microbial, Other Source

3) By Application: Oncology, Cellular and Gene Therapy, Blood And Blood-Related Products Development, Vaccine Development, Stem Cell Research, Other Applications

4) By End User: Pharmaceutical Industries, Biotechnology Industries, Contract Development And Manufacturing Organization(CDMO)

North America was the largest region in the biologics outsourcing market in 2022.

The table of contents in TBRC’s biologics outsourcing market report includes:

  1. Executive Summary
  2. Biologics Outsourcing Market Characteristics
  3. Biologics Outsourcing Market Trends And Strategies
  4. Biologics Outsourcing Market – Macro Economic Scenario
  5. Global Biologics Outsourcing Market Size and Growth


  1. Global Biologics Outsourcing Market Competitive Benchmarking
  2. Global Biologics Outsourcing Market Competitive Dashboard
  3. Key Mergers And Acquisitions In The Biologics Outsourcing Market
  4. Biologics Outsourcing Market Future Outlook and Potential Analysis
  5. Appendix

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:






Healthcare Blog:

Global Market Model:

Leave a Reply

Your email address will not be published. Required fields are marked *